Hepatology in Germany. Liver disease treatment.
In Germany, hepatological conditions are treated in gastroenterology departments and hospitals certified by the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS). The company msp group germany works exclusively with the top hepatology clinics in Germany, as ranked by the magazine Focus in its Focus-Klinikliste, a nationwide hospital ranking.
Patients are treated within controlled therapeutic protocols using innovative medicines. The endoscopy and sonography units, equipped with state-of-the-art technology, are certified in accordance with the standards of the European Society of Gastroenterology and the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS); they make it possible to perform every established diagnostic and therapeutic examination of the oesophagus, stomach, small and large intestine, gallbladder and bile ducts, liver, pancreas and endocrine glands.
The highest quality of diagnosis and treatment of hepatological conditions, including cancer, is ensured by superbly equipped endoscopy units and specialised laboratories.
Interventional endoscopy is used to deliver standard treatment for tumours of the gastrointestinal tract, liver, bile ducts and pancreas (laser therapy, placement of metal and plastic stents, photodynamic therapy, etc.).
All types of systemic chemotherapy are administered in line with evidence-based protocols and the guidelines of the relevant specialist societies. All the gastroenterology hospitals and departments are certified by the German Cancer Society as cancer treatment centres.
Sound clinical practice is impossible without developing innovative forms of therapy through consistent scientific research and enriching well-proven clinical methods with new knowledge. Research work is integrated into the daily practice of the department of gastroenterology, metabolic diseases and intensive care medicine. The main areas of clinical research and specialisation of departments of gastroenterology, metabolic diseases and intensive care medicine are the pathogenesis of liver and bowel diseases and of metabolic syndrome.
Areas of experimental research
- liver inflammation and immunology;
- liver fibrosis;
- liver regeneration and experimental treatment methods;
- hepatocyte transplantation;
- the pathogenesis of liver cancer;
- bowel inflammation and immunology;
- the pathogenesis of diabetes mellitus;
- endocrine disorders;
- alpha-1 antitrypsin deficiency.
